Leerink Partners Upgrades Twist Bioscience to Outperform, Announces $70 Price Target
Benzinga Newsdesk 6 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Leerink Partners analyst Puneet Souda upgrades Twist Bioscience (NASDAQ:TWST) from Market Perform to Outperform and announces $70 price target.
Leerink Partners analyst Puneet Souda upgrades Twist Bioscience (NASDAQ:TWST) from Market Perform to Outperform and announces $70 price target.